Ipratropium 20mcgdo scfc fra 200-270 do 1000021950

This tender is for the supply of Ipratropium 20 mcg, a medication used to treat chronic obstructive pulmonary disease (COPD) and asthma. The description '20mcgdo scfc fra 200-270 do' suggests a specific dosage form and delivery method, likely a metered-dose inhaler (MDI) or a similar device delivering 20 micrograms per actuation ('mcgdo'), possibly in a specific formulation ('scfc fra') with a defined number of actuations per device (e.g., 200-270 actuations, 'do'). The reference number for this procurement is 1000021950. Ipratropium bromide is an anticholinergic bronchodilator that helps to relax the airways, making it easier to breathe. This tender is likely issued by a healthcare provider, such as a hospital or a public health service, seeking to replenish its stock of this essential respiratory medication. The tender specifications will outline the required pharmaceutical standards, packaging, labeling, expiry dates, and delivery schedules. Potential bidders must be qualified pharmaceutical suppliers or manufacturers with the capability to provide Ipratropium 20 mcg inhalers that meet all regulatory and quality requirements. The evaluation process will assess the product's compliance, the supplier's reliability, and the overall cost-effectiveness of the offer to ensure the consistent availability of this vital treatment for patients with respiratory conditions.

This is a services contract in the health and medical services, information and communication technology and general supplies sectors. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.